Han Heze, Chen Yu, Ma Li, Li Ruinan, Li Zhipeng, Zhang Haibin, Yuan Kexin, Wang Ke, Jin Hengwei, Meng Xiangyu, Yan Debin, Zhao Yang, Zhang Yukun, Jin Weitao, Li Runting, Lin Fa, Hao Qiang, Wang Hao, Ye Xun, Kang Shuai, Gao Dezhi, Sun Shibin, Liu Ali, Li Youxiang, Chen Xiaolin, Zhao Yuanli, Wang Shuo
Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
China National Clinical Research Center for Neurological Diseases, Beijing, China.
CNS Neurosci Ther. 2024 Apr;30(4):e14533. doi: 10.1111/cns.14533. Epub 2023 Nov 21.
To compare the efficacy and deficiency of conservative management (CM), microsurgery (MS) only, and microsurgery with preoperative embolization (E + MS) for unruptured arteriovenous malformations (AVMs).
We prospectively included unruptured AVMs undergoing CM, MS, and E + MS from our institution between August 2011 and August 2021. The primary outcomes were long-term neurofunctional outcomes and hemorrhagic stroke and death. In addition to the comparisons among CM, MS, and E + MS, E + MS was divided into single-staged hybrid and multi-staged E + MS for further analysis. Stabilized inverse probability of treatment weighting using propensity scores was applied to control for confounders by treatment indication across the three groups.
Of 3758 consecutive AVMs admitted, 718 patients were included finally (266 CM, 364 MS, and 88 E + MS). The median follow-up duration was 5.4 years. Compared with CM, interventions (MS and E + MS) were associated with neurological deterioration. MS could lower the risk of hemorrhagic stroke and death. Multi-staged E + MS was associated with neurological deterioration and higher hemorrhagic risks compared with MS, but the hybrid E + MS operation significantly reduced the hemorrhage risk.
In this study, unruptured AVMs receiving CM would expect better neurofunctional outcomes but bear higher risks of hemorrhage than MS or E + MS. The single-staged hybrid E + MS might be promising in reducing inter-procedural and subsequent hemorrhage.
比较保守治疗(CM)、单纯显微手术(MS)以及术前栓塞联合显微手术(E+MS)治疗未破裂动静脉畸形(AVM)的疗效与不足。
我们前瞻性纳入了2011年8月至2021年8月间在我院接受CM、MS和E+MS治疗的未破裂AVM患者。主要结局为长期神经功能结局、出血性卒中及死亡。除了比较CM、MS和E+MS外,E+MS又分为单期杂交手术和多期E+MS进行进一步分析。采用倾向评分的稳定逆概率治疗权重法,通过三组的治疗指征来控制混杂因素。
在连续收治的3758例AVM患者中,最终纳入718例(266例CM,364例MS,88例E+MS)。中位随访时间为5.4年。与CM相比,干预措施(MS和E+MS)与神经功能恶化相关。MS可降低出血性卒中和死亡风险。与MS相比,多期E+MS与神经功能恶化及更高的出血风险相关,但杂交E+MS手术显著降低了出血风险。
在本研究中,接受CM治疗的未破裂AVM患者神经功能结局可能更好,但比MS或E+MS承受更高的出血风险。单期杂交E+MS在降低术中及后续出血方面可能很有前景。